CONFIDENCE EX HIGH VISCOSITY BONE CEMENT

K062424 · Disc-O-Tech Medical Technologies, Ltd. · NDN · Sep 14, 2006 · Orthopedic

Device Facts

• Record ID: K062424
• Device Name: CONFIDENCE EX HIGH VISCOSITY BONE CEMENT
• Applicant: Disc-O-Tech Medical Technologies, Ltd.
• Product Code: NDN · Orthopedic
• Decision Date: Sep 14, 2006
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3027
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Disc-O-Tech Confidence EX High Viscosity Bone Cement is indicated for the fixation of pathological fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. Painful vertebral compression fractures may result from osteoporosis, benign lesions (hemangioma), and malignant lesions (metastatic cancer, myeloma).

Device Story

Confidence EX High Viscosity Bone Cement is a radiopaque, self-curing PMMA bone cement. It consists of a two-component system (22.5 g powder polymer and 9.2 g liquid monomer) mixed manually prior to use. The powder contains 30.07% barium sulfate for radiopacity. Used in clinical settings (OR/clinic) by physicians during vertebroplasty or kyphoplasty procedures to stabilize vertebral fractures. The cement is injected into the vertebral body to provide structural fixation, alleviating pain associated with fractures caused by osteoporosis or lesions. The high viscosity formulation is designed to facilitate controlled delivery during the procedure.

Clinical Evidence

No clinical data provided; substantial equivalence is based on technological characteristics and material properties.

Technological Characteristics

Radiopaque, self-curing PMMA bone cement. Two-component system: 22.5g powder (polymer) and 9.2g liquid (monomer). Contains 30.07% barium sulfate. High viscosity formulation. Provided sterile.

Indications for Use

Indicated for fixation of pathological vertebral body fractures via vertebroplasty or kyphoplasty. Patient population includes individuals with painful vertebral compression fractures due to osteoporosis, benign lesions (hemangioma), or malignant lesions (metastatic cancer, myeloma).

Regulatory Classification

Identification

Polymethylmethacrylate (PMMA) bone cement is a device intended to be implanted that is made from methylmethacrylate, polymethylmethacrylate, esters of methacrylic acid, or copolymers containing polymethylmethacrylate and polystyrene. The device is intended for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.

Special Controls

*Classification.* Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Polymethylmethacrylate (PMMA) Bone Cement.”

Predicate Devices

• Confidence High Viscosity Bone Cement (K060300)

Submission Summary (Full Text)

{0}------------------------------------------------

**510(K) SUMMARY**

SEP 1 4 2006

# Disc-O-Tech Medical Technologies Ltd.

## Confidence EX High Viscosity Bone Cement

#### Submitter Name

Disc-O-Tech Medical Technologies Ltd.

11 Ha'Hoshlim St.,

Herzeliya 46724, Israel

## Contact Person

1. Hila Wachsler-Avrahami

Disc-O-Tech Medical Technologies Ltd.

11 Ha'Hoshlim St., Herzeliya 46724, Israel

Tel: [phone], Fax: [phone]

- 2. Jonathan S. Kahan, Esq. Hogan & Hartson L.L.P 555 Thirteenth Street, NW, Washington, DC 20004 Tel: [phone], Fax: [phone]
## Date Prepared

August 2006

## Trade/Proprietary Name

Confidence EX High Viscosity Bone Cement

## Common Name

PMMA Bone Cement

{1}------------------------------------------------

#### Classification Name

Filler, Bone Cement (For Vertebroplasty)

### Classification

Class II, per 21 CFR §888.3027

### Predicate Devices

Disc-O-Tech's Confidence High Viscosity Bone Cement (K060300)

### Intended Use

The Disc-O-Tech Confidence EX High Viscosity Bone Cement is indicated for the fixation of pathological fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. Painful vertebral compression fractures may result from osteoporosis, benign lesions (hemangioma), and malignant lesions (metastatic cancer, myeloma).

### System Description

The Confidence EX High Viscosity Bone Cement is a radiopaque, self-curing, high viscosity PMMA bone cement. It is provided sterile, as a two-component system (22.5 g powder (polymer) and 9.2 g liquid (monomer)), which are mixed prior to use to form the cement. The powder component contains 30.07 % barium sulfate.

### Substantial Equivalence

Based on the information provided in this premarket notification, the Confidence EX High Viscosity Bone Cement intended use, chemical composition, material properties, biocompatibility, technological characteristics, performance, principles of operation, and clinical application are substantially equivalent to those of the predicate devices, and especially to those of the Confidence High Viscosity Bone Cement.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

## SEP 1 4 2006

Disc-O-Tech Medical Technologies, Ltd. % Jonathan S. Kahan, Esq. Hogan and Hartson, LLP 555 Thirteenth Street, NW Washington, DC 20004

Re: K062424

Trade/Device Name: Confidence EX High Viscosity Bone Cement Regulation Number: 21 CFR 888.3027 Regulation Name: Polymethylmethacrylate (PMMA) Bone Cement Regulatory Class: Class II Product Code: NDN Dated: August 14, 2006 Received: August 18, 2006

Dear Mr. Kahan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 – Mr. Jonathan S. Kahan

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone] . Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

flurbau (melur

Mark N. Melkerson Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

#### INDICATION FOR USE

510(K) Number (if known):

Confidence EX High Viscosity Bone Cement Device Name:

#### Indication for Use:

The Disc-O-Tech Confidence EX High Viscosity Bone Cement is indicated for the fixation of pathological fractures of the vertebral body using vertebroplasty or kyphoplasty procedures. Painful vertebral compression fractures may result from osteoporosis, benign lesions (hemangioma), and malignant lesions (metastatic cancer, myeloma).

Prescription Use _____________________________________________________________________________________________________________________________________________________________ ﺮ ﮨﮯ (Part 21 CFR 801 Subpart D) Over-The-Counter Use (Part 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

AND/OR

Concurrence of CDRH, Office of Device Evaluation (ODE)

Toubare buckum
**(Division Sign-Off)**

Division of General, Restorative, and Neurological Devices

510(k) Number K062424